Peptide Lab

KLOW

$109.99

Out of Stock

KLOW is a four-component capsule blend containing KPV, BPC-157, TB-500, and MOTS-c for exploratory laboratory research across inflammatory, tissue, mitochondrial, and peptide-signaling models.

SKURC-EX-KLOW-60CT
ManufacturerExodus
FormCapsule
Strength500 mcg (KPV), 500 mcg (BPC-157), 2 mg (TB-500), 2 mg (MOTS-c)
Size60 ct
Reported ResultPending COA
StockOut of Stock
Documentation StatusPending COA

Product Description

KLOW combines 500 mcg KPV, 500 mcg BPC-157, 2 mg TB-500, and 2 mg MOTS-c per labeled serving in a 60-capsule Exodus presentation. The components span distinct research areas: KPV is an alpha-MSH-derived tripeptide studied mainly in preclinical inflammatory and epithelial models; BPC-157 is studied in tissue and gastrointestinal models; TB-500 requires sequence verification and is associated with thymosin-beta-4-related research; and MOTS-c is a mitochondrial-derived peptide studied in metabolic signaling. There is no established evidence for the exact branded combination, oral bioavailability, or synergistic effect.

Storage and handling: Store capsules tightly sealed in a cool, dry location protected from heat, light, and moisture, unless the manufacturer specifies otherwise. Use the lot-specific COA/SDS for exact requirements.

For laboratory research use only. Not for human or animal consumption, personal use, dietary supplementation, wellness, performance, diagnosis, treatment, cure, or prevention.
Lab analysis

Third-party testing status.

Batch / LotReported ResultTestedPartnerStatusDocument
RC-SUP-TEMP-0526Lot documentationPendingPendingLot DocumentationLot Documentation